Suven Pharmaceuticals informs about disclosure

12 May 2025 Evaluate
Suven Pharmaceuticals has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 09, 2025 for Jusmiral Holdings.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

136.00 -0.90 (-0.66%)
23-Jan-2026 12:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1635.70
Dr. Reddys Lab 1241.60
Cipla 1380.25
Zydus Lifesciences 887.00
Lupin 2145.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×